Literature DB >> 7512400

Epitope mapping human heat shock protein 90 with sera from infected patients.

A M al-Dughaym1, R C Matthews, J P Burnie.   

Abstract

Epitope mapping with sera from a range of infected patients showed that antibodies are commonly produced which cross-react with a number of epitopes on human heat shock protein 90 (HSP 90). Such autoreactive antibodies were particularly frequent in patients suffering from systemic candidiasis (9 patients), invasive aspergillosis (6 patients), ABPA (2 patients), a patient with aspergilloma and one with malaria. The patient with malaria recognized similar epitopes to those with invasive aspergillosis and candidiasis including the highly conserved epitope LKVIRKVIRK and an epitope NNLGTI which was otherwise only recognised by patients with candidiasis. Crossreacting antibodies to relatively few epitopes occurred in patients with Enterococcus faecalis and Corynebacterium jeikeium endocarditis. This was contrasted with the results from 6 patients with systemic lupus erythematosus (SLE) who were positive on immunoblot against fungal HSP 90. These did not react with the above epitopes but reacted with other areas within human HSP 90.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512400     DOI: 10.1111/j.1574-695X.1994.tb00423.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  4 in total

Review 1.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Detection of antigens in mycelial and in arthroconidial phases of Trichophyton mentagrophytes.

Authors:  P Kopecek; E Weigl; M Raska
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

3.  Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90.

Authors:  Ruth C Matthews; Gordon Rigg; Samantha Hodgetts; Tracey Carter; Caroline Chapman; Carl Gregory; Chris Illidge; James Burnie
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  Defining antibody targets in Streptococcus oralis infection.

Authors:  J P Burnie; W Brooks; M Donohoe; S Hodgetts; A al-Ghamdi; R C Matthews
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.